AA&MDSIF is co-sponsoring three symposia intended to provide updates on the most recent research related to the biology and clinical management of bone marrow failure diseases, including myelodysplastic syndromes, aplastic anemia, paroxysmal nocturnal hemoglobinuria, and myeloproliferative neoplasms. The overall goal of each continuing education symposium is to facilitate the translation of research findings into clinical practice and to improve the care of these patient populations.
At each event, local and national Hematology/Oncology experts will focus on the latest advances in the diagnosis, genetic characteristics, pathology, and treatment options for these diseases. The intended audience for the symposium includes hematologists, medical oncologists, internists, pathologists, residents/fellows, physician assistants, nurse practitioners, nurses, and allied health professionals treating patients with bone marrow failure diseases.
Saturday, September 27, 2014
8:00 am to 4:00 pm
The Hotel Hershey, 100 Hotel Road, Hershey, PA 17033
8:00 – 8:30 am Registration
& Continental Breakfast
8:30 am – 4:00 pm Program (lunch and breaks included)
- Raymond J. Hohl, MD, Ph.D., Professor of
Medicine and Director, Penn State Hershey Cancer Institute, Penn State
University School of Medicine
Title: Myelodysplastic Syndromes: Sixty and Maturing
- Richard W. Childs, MD, Clinical Director, Division
of Intramural Research (DIR), National Heart, Lung, and Blood Institute (NHLBI)
Title: Combined Transplantation with Umbilical Cord Blood and Haploidentical Stem Cells: A new and effective Treatment option for patients with Refractory Aplastic Anemia who lack HLA matched donors
- Robert A.
Brodsky, MD, Director, Division of Hematology, Johns Hopkins Medicine Institute
Title: PNH and Bone Marrow Failure
Michael G. Bayerl, MD, Associate professor,
Department of Pathology, Penn State University School of Medicine
Title: Pathologic Considerations in Bone Marrow Failure and Mimics
Thomas P. Loughran, MD, Professor of Medicine
and Director, University of Virginia Cancer Center
Title: Pathogenesis of LGL leukemia
- Monica Bessler MD, PhD, Professor in Pediatrics
and Internal Medicine
Director, Pediatric & Adult Comprehensive Bone Marrow Failure Center
The Children’s Hospital of Philadelphia and The Hospital of the University of Pennsylvania
Title: Towards Precision Medicine in Bone Marrow Failure
- David F. Claxton, MD, Professor of Medicine, Penn State Hershey
Cancer Institute, Penn State University School of Medicine
Title: Genomic Analysis and Advances in the treatment of Acute Myeloid Leukemia
- Witold B. Rybka, MD, Professor and Director,
Stem Cell Transplant Program
Penn State Hershey Cancer Institute, Penn State University School of Medicine
Title: Critical Conditions in Hematopoietic Cell Engraftment
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and the Aplastic Anemia & MDS International Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing education for physicians.
Penn State College of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s) ™.